Author: Ian Conway

Ian Conway has worked in financial markets for over 30 years as a bond and equity trader, Extel-rated analyst and strategist, and partner of a stockbroking firm. He also founded a financial research company servicing institutional clients prior to writing for and editing Shares magazine. Ian is primarily an income investor although he also buys selected growth stocks. Find him at LinkedIn: Click Here

Debenhams board changes elicit mixed reaction

Having pleased the market last Thursday with a positive H1 trading update, fashion and beauty retailer Debenhams (LON:DEBS) received a mixed reaction to its board reshuffle. While the shares initially traded flat, broker Shore Capital called the changes ‘a missed opportunity’ and said it would no longer cover the stock. Back to the future Debenhams announced on Friday former board member Iain McDonald had been reappointed as non-exeuctive chair with immediate effect. McDonald served on the company’s board from June 2017 to February 2026 and replaces the current non-exec chair Tim Morris. The firm also announced the appointment of Michael…

Read More
Coming next week

The week of 21-25 September 2026 brings a healthy sprinkling of UK company results to keep investors busy. However, the diary is fairly skinny across the pond in the US, and fashion retailer H&M is the only name of note among European corporates. On Monday, results from Craneware (LON:CRW) will be closely watched following a recent profit warning. The healthcare software firm needs to restore confidence in its growth story. Tuesday gets underway with a Q3 trading update from specialist employment group SThree (LON:STEM), which will give investors a read on the jobs market. And retail watchers will be scrutinising updates from…

Read More
Merchants Trust maintains Dividend Hero status after H1 outperformance

Value- and income-focused Merchants Trust (LON:MRCH) has maintained its AIC ‘Dividend Hero’ status after a strong H1 performance. The trust, which has raised its dividend over 44 consecutive years, beat its benchmark in the six months to July 2026. Outperforming a volatile market Despite an ‘unsettled’ political, economic and market backdrop, Merchants delivered a 9.3% net asset value (NAV) total return. The total share price return was 8.4% compared to a 7.9% return for FTSE All-Share index. However, there was ‘considerable movement beneath the surface’, admitted outgoing chair Colin Clark. ‘Individual sectors and stocks have experienced unusually wide variations in…

Read More
Galliford Try beats and maintains confident outlook

Infrastructure group Galliford Try (LON:GFRD) posted FY26 earnings which beat market forecasts and maintained its confident outlook. The firm also announced a new £15 million capital return capital by way of a new share buyback programme. Earnings beat expectations Galliford specialises in water and wastewater projects, highways, education, defence, prisons, facilities management and health. It also has a growing presence in affordable homes and the energy sector. Revenue for the year to June 2026 rose 3% to £1.93 billion driven by Highways work and the start of AMP8 in the Environment division. Pre-tax profit rose 24% to £55.9 million, driven…

Read More
Beauty Tech Grooup beats expectations again

At-home beauty technology firm The Beauty Tech Group (LON:TBTG) posted H1 results which beat expectations across the board. In addition, with a seasonally strong H2 in prospect, the company raised its adjusted EBITDA guidance for the full year. Revenue and margins beat expectations For the six months to June, the group increased revenue by 44% to £79.7 million. The at-home category is growing at a much faster rate than the wider beauty market yet still represents just 1% of beauty spending. Gross profit, which is earnings after the cost of sales, rose 53% to £51.3 million. That represented an H1…

Read More
Why now is the time to check your State Pension

When was the last time you checked your State Pension forecast, or have you never looked at it? According to HMRC, almost seven million people or one in eight adults have never checked their State Pension. Considering the State Pension is key to most people’s retirement planning, that’s a staggeringly high number. Therefore, as part of its Pensions Awareness Week campaign, HMRC is encouraging people of all ages to check their forecast. You can download and use the free, secure HMRC app, and you can visit the Tax Confident website for information on tax in retirement. ‘It’s never too early,…

Read More
Barratt Redrow lowers target for future completions

Housebuilder Barratt Redrow (LON:BTRW) lowered its target for future housing completions alongside its final FY26 results. The downgrade will be a further disappointment to those hoping for signs of an early upturn in the UK new-build housing market. Lowering its target for FY27 completions For the year to June 2027, Barratt Redrow cut its forecast for housing completions from a midpoint of around 18,000 units to 17,700 units. The firm said its new target included around 600 completions from joint ventures, in line with its previous target. The downgrade came in spite of an uptick in the net private weekly…

Read More
Eagle Eye results herald a bright future in store

Full-year results from AI-powered loyalty and promotions firm Eagle Eye Solutions (LON:EYE) beat previously raised expectations, heralding a bright future. The company also delivered on all four of its strategic objectives, with CEO Tim Mason calling FY26 a ‘transformational’ year. Results ahead of raised market expectations For the year to June, Eagle Eye reported annual recurring revenue (ARR) of £44.5 million, beating its previously raised target. SaaS (software as a service) revenue represented 85% of group turnover, showing continued progress in delivering recurring revenue growth. Significantly, EagleAI revenue grew at a faster clip, up 35% to £7.8 million, reflecting increased…

Read More
Personal Group H1 growth boosted by insurance

AIM-listed workplace benefits and insurance provider Personal Group (LON:PGH) posted strong growth in H1 revenue boosted by new insurance sales. The period marked a record for new sales, driven by new business and higher average premiums as the firm grows its footprint. Strong growth in insurance sales Group revenue for H1 rose 10% to £25.7 million, with more than 90% coming from recurring business. Within that, insurance revenue rose 11% to £19.4 million with new annualised sales up 9% to £8.1 million. Adjusted EBITDA rose 22% to £6.7 million while pre-tax profit rose 21% to £4.6 million. Return on tangible…

Read More
GSK gains on positive trial data for new cancer drugs

Shares in pharmaceutical giant GSK (LON:GSK) gained on positive trial results for two of its new cancer drugs. The company presented the results at the 2026 World Conference on Lung Cancer in Seoul, South Korea. Positive results for two drugs In the first trial, the firm’s Jideytro treatment delivered positive results in patients with non-small cell lung cancer. An inpressive 94% of patients experienced a positive response, including 15% who experienced a complete positive response 15 months later. Progression-free survival was 90% at 12 months, and the treatment produced similarly impressive results in patients with brain tumours. 100% of patients…

Read More